Cellular and extracellular markers of hemangioma.
Several cellular and extracellular markers that distinguish the phases of the hemangioma life cycle have been described previously. However, details of the phenotypic changes of; the various cellular elements during hemangioma development have not been fully reported, and the extracellular matrix composition, especially in the vicinity of the proliferating endothelial cells, is poorly described. This study examined the expression of cellular and extracellular molecules and cytokines in the proliferative, involuting, and involuted phases of hemangioma. Paraffin-embedded hemangioma specimens, four from each phase, were examined histochemically and immunohistochemically. Throughout the three phases, vascular endothelial cells stained positive for CD31 and von Willebrand factor, although in the involuted phase, not all vessels in the tissue expressed these endothelial markers. Proliferating cell nuclear antigen was expressed by the majority of endothelial cells and pericytes in the proliferative and early involuting phases, but its expression was negligible in the involuted phase. In addition to finding that the total number of mast cells was highest in the involuting phase, the authors observed that the proportion of chymase-positive mast cells decreased with the progression of hemangioma and that virtually all mast cells expressed the biogenic amine phenotype throughout the hemangioma life cycle. The localization of vascular endothelial growth factor predominantly to the pericytes and endothelial cells during the proliferative phase and of basic fibroblast growth factor to the endothelial cells in both the proliferative and early involuting phases is consistent with previous reports, although the latter growth factorwas also observed in mast cells. Type IV collagen and the beta chain of laminin and perlecan were detected in the basement membranes in all phases. Interestingly, collagen types I, III, and V were present in basal membranes throughout the phases and with increasing density in the stromal areas with involution, although type I collagen was less prominent during the proliferative phase. Short-chain collagen type VIII was localized extracellularly throughout the development of hemangioma but, during the early proliferative phase, it was also detected within mast cells. The expression of specific cytokines and cellular and extracellular markers may help distinguish the different clinical phases of the hemangioima life cycle. These results provide further insight into the biology of hemangioma.
Tan
S T
ST
Swee Tan Plastic Surgery Trust and the Department of Medicine, Wellington School of Medicine, New Zealand. sweetan@plastsurg.co.nz
Velickovic
M
M
Ruger
B M
BM
Davis
P F
PF
D034961:Antigens, Nuclear; D014408:Biomarkers, Tumor / Q000032:analysis*; D002452:Cell Count; D002648:Child; D002675:Child, Preschool; D003094:Collagen / Q000032:analysis; D016207:Cytokines / Q000032:analysis; D004730:Endothelium, Vascular / Q000473:pathology; D005260:Female; D006391:Hemangioma / Q000378:metabolism* / Q000473:pathology*; D006651:Histocytochemistry; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D007231:Infant, Newborn; D007797:Laminin / Q000032:analysis; D008407:Mast Cells / Q000473:pathology; D009687:Nuclear Proteins / Q000032:analysis; D012983:Soft Tissue Neoplasms / Q000378:metabolism* / Q000473:pathology*
D034961:Antigens, Nuclear; D014408:Biomarkers, Tumor; D016207:Cytokines; D007797:Laminin; D009687:Nuclear Proteins; D003094:Collagen